• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Vanda Pharmaceuticals, Inc. (VNDA)

    -NasdaqGM
    12.25 0.48(3.77%) Dec 19, 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 14,783   10,862   9,143   8,783  
    Cost of Revenue703  198   -   -  
    Gross Profit 14,080   10,664   9,143   8,783  
    Operating Expenses
    Research Development3,702  3,514  7,263  5,957  
    Selling General and Administrative11,289  28,139  27,893  9,440  
    Non Recurring -   -   -   -  
    Others536  617  565  377  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (1,447) (21,606) (26,578) (6,991)
    Income from Continuing Operations
    Total Other Income/Expenses Net22  31  45  44  
    Earnings Before Interest And Taxes(1,425)(21,575)(26,533)(6,947)
    Interest Expense -   -   -   -  
    Income Before Tax(1,425)(21,575)(26,533)(6,947)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(1,425)(21,575)(26,533)(6,947)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (1,425) (21,575) (26,533) (6,947)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (1,425) (21,575) (26,533) (6,947)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.